Molina Healthcare (NYSE:MOH) Given New $180.00 Price Target at Truist Financial

Molina Healthcare (NYSE:MOH) had its price target lifted by Truist Financial from $145.00 to $180.00 in a report released on Monday morning, Marketbeat reports. Truist Financial currently has a hold rating on the stock.

Several other research analysts also recently commented on MOH. Wall Street Zen upgraded Molina Healthcare from a “strong sell” rating to a “sell” rating in a research note on Sunday, April 19th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $129.00 price objective on shares of Molina Healthcare in a research report on Friday. Sanford C. Bernstein reissued an “outperform” rating on shares of Molina Healthcare in a research report on Friday, March 13th. Mizuho reduced their target price on shares of Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a report on Thursday, March 12th. Finally, Cantor Fitzgerald decreased their price target on shares of Molina Healthcare from $180.00 to $144.00 and set a “neutral” rating on the stock in a research note on Monday, February 9th. Two analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $163.86.

Molina Healthcare Stock Up 1.9%

Shares of MOH stock opened at $179.27 on Monday. Molina Healthcare has a 52-week low of $121.06 and a 52-week high of $333.00. The stock has a market cap of $9.34 billion, a price-to-earnings ratio of 53.04, a PEG ratio of 1.76 and a beta of 0.55. The firm’s 50-day moving average is $146.80 and its 200-day moving average is $158.51. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.Molina Healthcare’s quarterly revenue was down 3.1% on a year-over-year basis. During the same quarter last year, the company posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Sell-side analysts predict that Molina Healthcare will post 5.15 EPS for the current year.

Institutional Investors Weigh In On Molina Healthcare

A number of institutional investors have recently modified their holdings of the business. Torren Management LLC bought a new position in Molina Healthcare during the fourth quarter worth about $26,000. Miller Global Investments LLC acquired a new position in shares of Molina Healthcare during the 4th quarter worth approximately $27,000. Physician Wealth Advisors Inc. increased its holdings in shares of Molina Healthcare by 1,250.0% during the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock worth $29,000 after purchasing an additional 200 shares during the period. Cromwell Holdings LLC raised its position in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock valued at $32,000 after buying an additional 125 shares in the last quarter. Finally, Quarry LP bought a new stake in shares of Molina Healthcare in the fourth quarter valued at approximately $32,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.